{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:42:24Z","timestamp":1787013744527,"version":"build-2736575974"},"reference-count":27,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J of Rheum Dis"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to explore the association between inpatient gout flare\u2010related variables and the length of stay (LOS) in hospitalized people with comorbid gout.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using data from the Aotearoa\/New Zealand national data collections, this cohort study included adults with comorbid gout who were admitted to publicly funded hospitals during 2017 for reasons other than gout. The primary outcome was LOS. Association between 20 variables and the LOS was explored using two generalized linear models. Directed acyclic graph (DAG) was constructed to evaluate the causal relationship between pre\u2010admission urate lowering therapy (ULT) and LOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort included 36 047 admissions. We identified five variables associated with shorter LOS (pre\u2010admission regular urate\u2010lowering therapy (ULT), serum urate testing, male gender, M\u0101ori ethnicity and low\u2010dose aspirin) and seven variables associated with longer LOS (M3 multimorbidity index, acute admission, operation, loop diuretics, potassium\u2010sparing diuretics, NSAIDs, and age). Regular ULT had the strongest impact on shorter LOS (10% shorter). The model estimated an additional four days of hospitalization if the patient had multiple variables associated with longer LOS. DAG suggested a causal relationship between regular ULT and LOS under the condition that all unobserved confounders affected only ULT use, with no impact on in\u2010hospital gout flares and\/or LOS except through its influence on ULT use or as mediator of confounders that were observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We have identified a set of gout flare\u2010related variables found to be associated with LOS in hospitalized people with comorbid gout. Pre\u2010admission ULT may help reduce the LOS in such patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/1756-185x.14250","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T01:11:31Z","timestamp":1637284291000},"page":"154-162","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Regular pre\u2010admission urate\u2010lowering therapy and serum urate testing are associated with a shorter hospital length of stay in people with gout: A nation\u2010wide population\u2010based cohort study"],"prefix":"10.1111","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9301-8941","authenticated-orcid":false,"given":"Kanon","family":"Jatuworapruk","sequence":"first","affiliation":[{"name":"Department of Medicine University of Otago  Wellington New Zealand"},{"name":"Department of Medicine Faculty of Medicine Thammasat University  Pathumthani Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9201-8678","authenticated-orcid":false,"given":"Rebecca","family":"Grainger","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Otago  Wellington New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4632-4476","authenticated-orcid":false,"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Auckland  Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6075-8479","authenticated-orcid":false,"given":"William J.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Otago  Wellington New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"issue":"1","key":"e_1_2_9_2_1","first-page":"27","article-title":"Gout: state of the art after a decade of developments","volume":"58","author":"Pascart T","year":"2019","journal-title":"Rheumatology"},{"issue":"1485","key":"e_1_2_9_3_1","first-page":"8","article-title":"Gout in Aotearoa New Zealand: the equity crisis continues in plain sight","volume":"131","author":"Dalbeth N","year":"2018","journal-title":"N Zealand Med J"},{"issue":"1404","key":"e_1_2_9_4_1","first-page":"37","article-title":"Variation in gout care in Aotearoa New Zealand: a national analysis of quality markers","volume":"127","author":"Jackson G","year":"2014","journal-title":"N Zealand Med J"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.171320"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216277"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2012.02747.x"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e31820543c5"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2010.02165.x"},{"issue":"5","key":"e_1_2_9_10_1","first-page":"679","article-title":"Drug\u2010induced hyperuricaemia and gout","volume":"56","author":"Ben Salem C","year":"2017","journal-title":"Rheumatology"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker361"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.08.005"},{"key":"e_1_2_9_13_1","volume-title":"NZDep2013 Index of Deprivation Wellington, New Zealand","author":"Atkinson J","year":"2014"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2014.12.014"},{"issue":"6","key":"e_1_2_9_15_1","first-page":"1887","article-title":"Robust causal inference using directed acyclic graphs: the R package 'dagitty'","volume":"45","author":"Textor J","year":"2016","journal-title":"Int J Epidemiol"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781139025751"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024260023851"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-14-26"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00264-017-3425-2"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex442"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfv086"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.04.027"},{"issue":"7","key":"e_1_2_9_23_1","first-page":"1341","article-title":"Recent diuretic use and the risk of recurrent gout attacks: the online case\u2010crossover gout study","volume":"33","author":"Hunter DJ","year":"2006","journal-title":"J Rheumatol"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2013.66"},{"issue":"1508","key":"e_1_2_9_25_1","first-page":"29","article-title":"Trends in length of stay following acute coronary syndrome hospitalisation in New Zealand 2006\u20132016: ANZACS\u2010QI 32 study","volume":"133","author":"Wang TKM","year":"2020","journal-title":"N Zealand Med J"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16234789"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-021689"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000317"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1756-185X.14250","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1756-185X.14250","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1756-185X.14250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T04:42:01Z","timestamp":1693197721000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1756-185X.14250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1111\/1756-185X.14250"],"URL":"https:\/\/doi.org\/10.1111\/1756-185x.14250","archive":["Portico"],"relation":{},"ISSN":["1756-1841","1756-185X"],"issn-type":[{"value":"1756-1841","type":"print"},{"value":"1756-185X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]},"assertion":[{"value":"2021-01-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}